SCHEMBL5343341

SCHEMBL5343341

CC(C)(C)[Si](C)(C)OC1CN[C@H](C(=O)O)C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.42
CYP1A2 P05177 2/20 0.42
ALOX15 P16050 2/20 0.42
CYP2C19 P33261 2/20 0.42
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
PPM1D O15297 1/20 0.34
ARG1 P05089 1/20 0.34
LMNA P02545 2/20 0.32
BLM P54132 2/20 0.32
TSHR P16473 1/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
PMP22 Q01453 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865098 1.00 CYP2D6 (0.42) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL4156977 1.00 CYP2D6 (0.42) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL27156766 1.00 CYP2D6 (0.42) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL18609999 1.00 CYP2D6 (0.42) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL15145321 1.00 CYP2D6 (0.42) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL18474094 0.84 CHRNB2 (0.33) PPM1D
SCHEMBL18610000 0.84 CHRNB2 (0.33) PPM1D
SCHEMBL3428965 0.84 CHRNB2 (0.33) PPM1D
SCHEMBL30591392 0.84 CHRNB2 (0.33) PPM1D
SCHEMBL29819954 0.84 CHRNB2 (0.33) PPM1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279601-B2 Optically active α-aminooxyketone derivatives and process for production thereof TOKYO UNIVERSITY OF SCIENCE, CENTER FOR SCIENCE AND TECHNOLOGY EXCHANGE (JP) 2007-10-09 US disclosed
US-20060293525-A1 Optically active alpha-aminooxyketone derivatives and process for production thereof TOKYO UNIVERSITY OF SCIENCE, CENTER FOR SCIENCE AND TECHNOLOGY EXCHANGE (JP) 2006-12-28 US disclosed
EP-1661885-A1 OPTICALLY ACTIVE ALPHA-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF Tokyo University of Science (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293525-A1 Optically active alpha-aminooxyketone derivatives and process for production thereof ALDH7A1, ASPH, KMO CYP2D6 816/4885CYP1A2 128/4885ALOX15 593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.